OSAKA -- Japanese drugmaker Shionogi's COVID-19 vaccine candidate was found to be as effective as Pfizer shots as a booster in a late-stage clinical trial, the company announced Friday.
"We saw extremely positive results, and we hope to accelerate development," President and CEO Isao Teshirogi told reporters.
